Handbook Of Neuroemergency Clinical Trials

Hardcover | December 15, 2005

byWayne M. AlvesEditorBrett E. Skolnick

not yet rated|write a review
During the 1990 s, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs. Numerous novel compounds were tested, and seemingly fell by the wayside. This book is intended to focus on novel therapies and the unique challenges their intended targets pose for the design and analysis of clinical trials. The authors explore the issues facing research in this area and the strategies that might lead to future success in this critical area of unmet medical need. It represents a compendium of information gained from over 20 years of clinical trial experience in areas of acute neurology and neurosurgery. From the knowledge of clinical assessment using standardized tools, to the intricate design of difficult hyper-acute neuroemergencies trials, the reader will benefit from the authors perspectives. * Presents new perspectives on acute neuroemergency clinical trials * Includes insights from clinical pharmacology and industry perspectives* Discusses historical lessons learned from early and recent trials in acute neuroscience populations

Pricing and Purchase Info

$305.30 online
$338.50 list price (save 9%)
In stock online
Ships free on orders over $25

From the Publisher

During the 1990 s, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs. Numerous novel compounds were tested, and seemingly fell by the wayside. This book is intended...

From the Jacket

During the 1990 s, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury, especially the neurochemical cascade associated with secondary brain injuries that occur most prominently with stroke and trauma, were offset by a history of disappointing results from Phase III clinical tr...

Dr. Alves is Vice President of Clinical Operations at Evoke Pharmaceuticals, Inc. in Solana, California. He has held academic positions conducting basic clinical research in neuroemergency populations, and has served as consultant to numerous companies seeking to develop novel drugs.Dr. Skolnick is a Clinical Associate Professor of Neu...
Format:HardcoverDimensions:360 pages, 10.25 × 7.25 × 0.98 inPublished:December 15, 2005Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0126480826

ISBN - 13:9780126480825

Look for similar items by category:

Customer Reviews of Handbook Of Neuroemergency Clinical Trials

Reviews

Extra Content

Table of Contents

STROKE AND TRAUMA
1. Acute Ischemic Stroke (Christopher Bladin, Stephen Davis)
2. Subarachnoid Hemorrhage (Nader Pouratian, Aaron S. Dumont, Neal F. Kassell)
3. Spontaneous Intracerebral Hemorrhage (Michael D. Hill)
4. Traumatic Brain Injury (Lawrence F. Marshall, Wayne Alves)

CENTRAL NERVOUS SYSTEM EMERGENCIES
5. Acute Seizures and Status Epilepticus (Susan T. Herman)
6. Clinical Trials in Neuro-opthamology (Laura Balcer, Madhura A. Tamhankar)
7. Brain Resuscitation (Edwin M. Nemoto)
8. Clinical Trials in Brain Injury after Cardiac Arrest (Romergryko G. Geocadin, Daniel F. Hanley)

SPECIAL ISSUES IN ACUTE NEUROSCIENCE CLINICAL TRIALS
9. Efficient Dose-Response Finding Strategies for Acute Neuroemergency Treatments (Tom Parke, Michael Krams, Peter Mueller, Don Berry)
10. Biostatistical Issues in Neuroemergency Clinical Trials (Wayne M. Alves)
11. Data and Safety Monitoring Boards (Brett Skolnick)
12. Role of the Project Medical Officer (Joseph Kwentus)
13. Ethical Considerations (Wayne Alves)

PERSPECTIVES ON NEUROEMERGENCY DRUG DEVELOPMENT
14. Industry Perspective on Drug Development (Thomas C. Wessel, Chris Gallen)
15. Regulatory Considerations (Lisa Travis)